Shari B Goldfarb1,2,3, Sabrina A Kamer1, Bridget A Oppong4, Anne Eaton5, Sujata Patil5, Manuela J Junqueira6, Cristina Olcese6, Joanne F Kelvin7, Mary L Gemignani8. 1. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 2. Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 3. Department of Medicine, Weill Cornell Medical College, New York, NY, USA. 4. Department of Surgery, Georgetown University Hospital, Washington, DC, USA. 5. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 6. Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 7. Memorial Sloan Kettering Cancer Center, New York, NY, USA. 8. Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. gemignam@mskcc.org.
Abstract
BACKGROUND: The American Society of Clinical Oncology (ASCO) guidelines include incorporation of fertility preservation guidelines in the care of breast oncology patients. This study aimed to examine the baseline knowledge and preferences concerning fertility preservation among women of childbearing age with newly diagnosed breast cancer at the time of their initial visit to Memorial Sloan Kettering Cancer Center (MSKCC). METHODS: A questionnaire on reproductive history, fertility knowledge, and preservation options was administered to women 18-45 years of age with newly diagnosed breast cancer at MSKCC between May and September 2011. RESULTS: The inclusion criteria were met by 60 women eligible for analysis who had a median age of 40 years (range 20-45 years). The findings showed that 50 % of the women either desired children in the future or were unsure whether they wanted children, with 9 % reporting that they received information about fertility preservation options before their MSKCC visit. Women who had never been pregnant were more likely than those with prior pregnancies to consider having children in the future (p = 0.001) and to contemplate fertility preservation options both before (p = 0.001) and after (p = 0.0002) cancer treatment. CONCLUSION: Early referral allows patients to take advantage of fertility preservation options while preventing delay in the initiation of systemic therapy. Referral by the breast surgical oncologist at the time of the initial visit has the potential to increase fertility knowledge because it appears that many women have not yet received fertility information at this early treatment stage.
BACKGROUND: The American Society of Clinical Oncology (ASCO) guidelines include incorporation of fertility preservation guidelines in the care of breast oncology patients. This study aimed to examine the baseline knowledge and preferences concerning fertility preservation among women of childbearing age with newly diagnosed breast cancer at the time of their initial visit to Memorial Sloan Kettering Cancer Center (MSKCC). METHODS: A questionnaire on reproductive history, fertility knowledge, and preservation options was administered to women 18-45 years of age with newly diagnosed breast cancer at MSKCC between May and September 2011. RESULTS: The inclusion criteria were met by 60 women eligible for analysis who had a median age of 40 years (range 20-45 years). The findings showed that 50 % of the women either desired children in the future or were unsure whether they wanted children, with 9 % reporting that they received information about fertility preservation options before their MSKCC visit. Women who had never been pregnant were more likely than those with prior pregnancies to consider having children in the future (p = 0.001) and to contemplate fertility preservation options both before (p = 0.001) and after (p = 0.0002) cancer treatment. CONCLUSION: Early referral allows patients to take advantage of fertility preservation options while preventing delay in the initiation of systemic therapy. Referral by the breast surgical oncologist at the time of the initial visit has the potential to increase fertility knowledge because it appears that many women have not yet received fertility information at this early treatment stage.
Authors: Halle C F Moore; Joseph M Unger; Kelly-Anne Phillips; Frances Boyle; Erika Hitre; David Porter; Prudence A Francis; Lori J Goldstein; Henry L Gomez; Carlos S Vallejos; Ann H Partridge; Shaker R Dakhil; Agustin A Garcia; Julie Gralow; Janine M Lombard; John F Forbes; Silvana Martino; William E Barlow; Carol J Fabian; Lori Minasian; Frank L Meyskens; Richard D Gelber; Gabriel N Hortobagyi; Kathy S Albain Journal: N Engl J Med Date: 2015-03-05 Impact factor: 91.245
Authors: Gwendolyn P Quinn; Susan T Vadaparampil; Ji-Hyun Lee; Paul B Jacobsen; Gerold Bepler; Johnathan Lancaster; David L Keefe; Terrance L Albrecht Journal: J Clin Oncol Date: 2009-10-13 Impact factor: 44.544
Authors: Shoshana M Rosenberg; Shari Gelber; Richard D Gelber; Ethan Krop; Larissa A Korde; Olivia Pagani; Ann H Partridge Journal: J Adolesc Young Adult Oncol Date: 2017-07-07 Impact factor: 2.223
Authors: Leah Hawkins Bressler; Jennifer E Mersereau; Chelsea Anderson; Juan L Rodriguez; M Elizabeth Hodgson; Clarice R Weinberg; Dale P Sandler; Hazel B Nichols Journal: Cancer Date: 2019-04-23 Impact factor: 6.860
Authors: Charles L Shapiro; Nicole Zubizarreta; Erin Moshier; Julia P Brockway; John Mandeli; Merry Jennifer Markham; Mary May Kozlik; Stephanie Crist; Paul B Jacobsen Journal: JCO Oncol Pract Date: 2021-07-20